A Trial of P2Y 12 Receptor Inhibition With Prasugrel Identifies a Potentially Distinct Endotype of Patients With Aspirin-Exacerbated Respiratory Disease

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.06.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis

Immunology and Allergy Clinics of North America
AllergyImmunology
2016English

A Retrospective Analysis of Esophageal Eosinophilia in Patients With Aspirin-Exacerbated Respiratory Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Role of Periostin in Brazilian Patients With Aspirin Exacerbated Respiratory Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Solute Carrier Family 6 Member 12 Gene Polymorphisms in Japanese Patients With Aspirin-Exacerbated Respiratory Disease

Journal of Allergy & Therapy
2015English

Metabolomic Analysis Identifies Potential Diagnostic Biomarkers for Aspirin-Exacerbated Respiratory Disease

Clinical and Experimental Allergy
AllergyImmunology
2016English

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease

Journal of Allergy
AllergyImmunology
2012English

Frequency of Anti-Inflammatory Related Cutaneous Manifestation in Patients With Aspirin-Exacerbated Respiratory Disease (AERD)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Association of L-Plastin Expression With Recalcitrant Nasal Polyps in the Patients With Aspirin-Exacerbated Respiratory Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Elevated Tryptase During Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy